|
|||||
|
|
Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial |
|
| Authors: | Isao Ohsawa Daisuke Honda Yusuke Suzuki Tomoo Fukuda Keisuke Kohga Eishin Morita Shinichi Moriwaki Osamu Ishikawa Yoshihiro Sasaki Masaki Tago Greg Chittick Melanie Cornpropst Sharon C. Murray Sylvia M. Dobo Eniko Nagy Sharon Van Dyke Lacy Reese Jessica M. Best Heather Iocca Phil Collis William P. Sheridan Michihiro Hide |
| Affiliation: | 1. Internal Medicine, Saiyu Soka Hospital, Saitama, Japan Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan;2. Juntendo University Urayasu Hospital, Chiba, Japan;3. Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan;4. Saitama Medical Center, Saitama, Japan;5. Community Hospital Kohga Hospital, Shizuoka, Japan;6. Shimane University Hospital, Shimane, Japan;7. Osaka Medical College Hospital, Osaka, Japan;8. Gunma University Hospital, Gunma, Japan;9. National Hospital Organization Disaster Medical Center, Tokyo, Japan Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine, Tokyo, Japan;10. Department of General Medicine, Saga University Hospital, Saga, Japan;11. BioCryst Pharmaceuticals, Inc, Durham, NC, USA;12. Hiroshima University, Hiroshima, Japan |
| Abstract: | |
| Keywords: | berotralstat hereditary angioedema Japan kallikrein inhibitor prophylaxis |